Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Integrase inhibitors are emerging anti-human immunodeficiency virus (HIV) drugs, and multiple retroviruses and transposable elements were evaluated here for susceptibilities to raltegravir (RAL) and elvitegravir (EVG). All viruses, including primate and nonprimate lentiviruses, a Betaretrovirus , a Gammaretrovirus , and the Alpharetrovirus Rous sarcoma virus (RSV), were susceptible to inhibition by RAL. EVG potently inhibited all lentiviruses and intermediately inhibited Betaretrovirus and Gammaretrovirus infections yet was basically ineffective against RSV. Substitutions based on HIV type 1 (HIV-1) resistance changes revealed that integrase residue Ser150 contributed significantly to the resistance of RSV. The drugs intermediately inhibited intracisternal A-particle retrotransposition but were inactive against Sleeping Beauty transposition and long interspersed nucleotide element 1 (LINE-1) retrotransposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Because retroviral IN active sites are highly conserved, INSTIs are broadly active across the retroviral family32,158,159 save the occasional example when an IN residue, such as Ser150 in ASLV IN, confers baseline resistance, in this case to elvitegravir39,160.”
From Structure and function of retroviral integrase (2022) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 55 · Cited by 37
Metadata
- Authors
- Koh, Y., Matreyek, K. A., & Engelman, A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Engelman, Alan
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 85
- Issue
- 7
- Pages
- 3677-3682
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3067883
- OpenAlex
- W2151347440
- Cited by
- 37
- References
- 55
- Citations by year
- 2026: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- Harvard University (P30AI060354)
- Harvard University Center for AIDS Research (P30 AI060354)
- National Institutes of Health (AI039394)
- Center for AIDS Research, University of Washington
- National Heart, Lung, and Blood Institute
- National Institute of Mental Health
- National Institute on Drug Abuse
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases (AI039394, R01AI039394, R37AI039394, P30AI060354)
- National Center for Complementary and Alternative Medicine
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- integrase strand transfer inhibitors, raltegravir, elvitegravir, lentivirus, Rous sarcoma virus, LINE-1 retrotransposition, transposable elements, antiviral resistance
- MeSH terms
- Raltegravir Potassium, Animals, Antiviral Agents, Humans, Primates, Pyrrolidinones, Retroviridae, Quinolones, Virus Integration, Retroelements, Integrases, Drug Resistance, Viral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors. https://app.cochat.ai/papers/10.1128/jvi.02541-10
- The paper
- Koh, Y., Matreyek, K. A., & Engelman, A. (2011). Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors. Journal of Virology. https://doi.org/10.1128/jvi.02541-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.